Drug intelligence / Profile preview

Zhanrong

Development stage: Unknown
Lead developer: Junion Therapeutics
Administration: Oral

Overview

Zhanrong is a Chinese herbal medicine formulation, specifically available as "Zhanrong capsules," developed for the treatment of overweight and obesity. It is classified as a traditional Chinese medicine (TCM) product and contains multiple herbal ingredients, though the precise composition is not detailed in public sources. The mechanism of action likely involves modulation of metabolic pathways and appetite regulation, consistent with other TCM weight loss formulations. The product is being evaluated in clinical trials for its efficacy in weight management among overweight or obese individuals[1]. No evidence suggests it contains conventional pharmaceutical active ingredients or that it follows a single-target mechanism typical of Western drugs.

Brand names: Zhanrong
Other names: Zhanrong capsules

Beyond the preview

Go deeper on Zhanrong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhanrong.

Explore the full profile